Hematologist (Assistant Director Hematology Oncology Department)
Benjamin Mkapa Hospital
University of Dodoma
Dodoma, Dodoma, Tanzania
Dr. Stella Malangahe, from the Catholic University of Healthy and Allied Sciences, formerly known as Weill BUCHS, and a Master of Medicine in Haematology and Blood Transfusion (2017) from the Muhimbili University of Health and Allied Sciences in Tanzania. She is an Assistant Director in the Department of Haematology and Oncology at Benjamin Mkapa Hospital (BMH). As a clinician, soon after joining BMH in 2018, she managed to start the Hematology department which offers a range of specialised haematological services to almost 5 regions (Dodoma, Singida, Iringa, Manyara and Tabora) through provision of specialised care; both outpatient and inpatient services.
As she continued to serve, she learnt the huge demand and gap in terms of advanced treatment : exchange transfusion bone marrow transplant , for patients with hematology disorders. In collaboration with the Department of Pediatrics at University of Dodoma and Italian collaborators (HELP3) in 2023 she leads a team that performed the 1st (Allogeneic) Bone Marrow Transplant in patients with Sickle cell disease in Tanzania. This makes Tanzania the 1st country in East and Central Africa and the 6th in Africa to excel in such a rare and needy curative service worldwide.
She hopes to continue bringing an endless smile to her patients by expanding this curative services to other haematological diseases such as Aplastic anemia and acute leukemia and later to other non-haematological disorders that require Bone marrow transplant treatment.
She participates in the National-Non Communicable Disease- Sickle Cell Disease programme as Master Trainer, coordinated by the Ministry of Health through Tanzania Nutrition and Diabetes Association (TNDA). She works with PenPlus WHO programme which integrates care delivery to people with NCDs to less privileged communities located in mid and low income countries including SCD, DM 1 and rheumatic heart disease. She also conducts patients, healthcare workers and community, SCD educative sessions through Radio, Televisions and through social media platforms.
Disclosure information not submitted.
PENPlus –integration of sickle cell disease into primary care
Sunday, June 9, 2024
11:35 AM – 11:50 AM ET